The weekly litigation news digest is live. Subscribe now

IP Verse

Nissui competitive analysis

Loading summary...

Latest patents of Nissui opposed by its competitors

Explore Nissui's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 4, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3632422
Oct 16, 2024Composition For Improving Vascular Endothelial Function1
EP3971165
Aug 7, 2024Highly Unsaturated Fatty Acid Or Highly Unsaturated Fatty Acid Ethyl Ester With Reduced Environmental Pollutants, And Method For Producing Same1
EP2682453
Mar 22, 2023Method Of Producing Oil/Fat Comprising Highly-Unsaturated Fatty Acids By Means Of Lipase1
EP2851361
Nov 24, 2021Highly Unsaturated Fatty Acid Or Highly Unsaturated Fatty Acid Ethyl Ester With Reduced Environmental Pollutants, And Method For Producing Same1

Latest PTAB cases involving Nissui

Discover the latest PTAB cases involving Nissui, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Nissui with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NISSUI - 4 - -
EPAX NORWAY31 - -
KD PHARMA BEXBACH2 - - -
PRONOVA BIOPHARMA NORGE1 - - 1